Dement Neurocogn Disord.  2017 Jun;16(2):33-39. 10.12779/dnd.2017.16.2.33.

Anxiety in Dementia

• Kwak YT
• Yang Y
• Koo MS

• KMID: 2442824
• DOI: http://doi.org/10.12779/dnd.2017.16.2.33

Abstract

Until recently, there is considerable mess regarding the nature of anxiety in dementia. However, anxiety is common in this population affecting from 8% to 71% of prevalence, and resulted in poor outcome and quality of life, even after controlling for depression. Because a presentation of anxiety in the context of dementia can be different from typical early-onset anxiety disorder, it is not easy one to identify and quantify anxiety reliably. Moreover, differentiating anxiety from the depression and/or dementia itself also can be formidable task. Anxiety gradually decreases at the severe stages of dementia and this symptom may be more common in vascular dementia than in Alzheimer's disease. Due to the lack of large randomized clinical trials, optimal treatment and the true degree of efficacy of treatment is not clear yet in this population. However, these treatments can reduce adverse impact of anxiety on patients and caregivers. This article provides a brief review for the diagnosis, evaluation and treatment of anxiety in dementia.

Keyword

anxiety; dementia; vascular dementia; Alzheimer's disease

MeSH Terms

Alzheimer Disease
Anxiety Disorders
Anxiety*
Caregivers
Dementia*
Dementia, Vascular
Depression
Diagnosis
Humans
Prevalence
Quality of Life

Reference

1. Shankar KK, Orrell MW. Detecting and managing depression and anxiety in people with dementia. Curr Opin Psychiatry. 2000; 13:55–59.

2. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O'Connor SM, Rosenberg-Thompson S, et al. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003; 15:180–186. PMID: 12724459.

3. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry. 2000; 157:708–714. PMID: 10784462.

4. Gibbons LE, Teri L, Logsdon R, McCurry SM, Kukull W, Bowen J, et al. Anxiety symptoms as predictors of nursing home placement in patients with Alzheimer's disease. J Clin Geropsychol. 2002; 8:335–342.

5. Beekman AT, Bremmer MA, Deeg DJ, van Balkom AJ, Smit JH, de Beurs E, et al. Anxiety disorders in later life: a report from the longitudinal aging study Amsterdam. Int J Geriatr Psychiatry. 1998; 13:717–726. PMID: 9818308.

6. Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord. 2000; 59:97–106. PMID: 10837878.

7. Mendez MF, McMurtray A, Chen AK, Shapira JS, Mishkin F, Miller BL. Functional neuroimaging and presenting psychiatric features in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2006; 77:4–7. PMID: 16043457.

8. Chen JC, Borson S, Scanlan JM. Stage-specific prevalence of behavioral symptoms in Alzheimer's disease in a multi-ethnic community sample. Am J Geriatr Psychiatry. 2000; 8:123–133. PMID: 10804073.

9. Aarsland D, Cummings JL, Larsen JP. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001; 16:184–191. PMID: 11241724.

10. Seignourel PJ, Kunik ME, Snow L, Wilson N, Stanley M. Anxiety in dementia: a critical review. Clin Psychol Rev. 2008; 28:1071–1082. PMID: 18555569.

11. Tanaka H, Hashimoto M, Fukuhara R, Ishikawa T, Yatabe Y, Kaneda K, et al. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease. Psychogeriatrics. 2015; 15:242–247. PMID: 25737233.

12. Kwak YT, Yang YS, Kwak SG. Clinical characteristics of behavioral and psychological symptoms in patients with drug-naïve Alzheimer's disease. Dement Neurocogn Disorder. 2012; 11:87–94.

13. Brodaty H, Connors MH, Xu J, Woodward M, Ames D. PRIME study group. The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study. J Am Med Dir Assoc. 2015; 16:380–387. PMID: 25687925.

14. McClive-Reed KP, Gellis ZD. Anxiety and related symptoms in older persons with dementia: directions for practice. J Gerontol Soc Work. 2011; 54:6–28. PMID: 21170777.

15. Starkstein SE, Jorge R, Petracca G, Robinson RG. The construct of generalized anxiety disorder in Alzheimer disease. Am J Geriatr Psychiatry. 2007; 15:42–49. PMID: 17194814.

16. Neville C, Teri L. Anxiety, anxiety symptoms, and associations among older people with dementia in assisted-living facilities. Int J Ment Health Nurs. 2011; 20:195–201. PMID: 21492359.

17. Bergh S, Selbæk G. The prevalence and the course of neuropsychiatric symptoms in patients with dementia. Nor Epidemiol. 2012; 22:225–232.

18. Bierman EJ, Comijs HC, Jonker C, Beekman AT. Symptoms of anxiety and depression in the course of cognitive decline. Dement Geriatr Cogn Disord. 2007; 24:213–219. PMID: 17690554.

19. Calleo J, Stanley M. Anxiety disorders in later life: differentiated diagnosis and treatment strategies. Psychiatr Times. 2008; 25:24–27.

20. Calleo JS, Kunik ME, Reid D, Kraus-Schuman C, Paukert A, Regev T, et al. Characteristics of generalized anxiety disorder in patients with dementia. Am J Alzheimers Dis Other Demen. 2011; 26:492–497. PMID: 22062223.

21. Rozzini L, Chilovi BV, Peli M, Conti M, Rozzini R, Trabucchi M, et al. Anxiety symptoms in mild cognitive impairment. Int J Geriatr Psychiatry. 2009; 24:300–305. PMID: 18759379.

22. Bierman EJ, Comijs HC, Jonker C, Scheltens P, Beekman AT. The effect of anxiety and depression on decline of memory function in Alzheimer's disease. Int Psychogeriatr. 2009; 21:1142–1147. PMID: 19615124.

23. Gallacher J, Bayer A, Fish M, Pickering J, Pedro S, Dunstan F, et al. Does anxiety affect risk of dementia? Findings from the Caerphilly prospective study. Psychosom Med. 2009; 71:659–666. PMID: 19553290.

24. Derouesné C, Rapin JR, Lacomblez L. [Memory complaints in 200 subjects meeting the diagnostic criteria for age-associated memory impairment: psychoaffective and cognitive correlates]. Psychol Neuropsychiatr Vieil. 2004; 2:67–74. PMID: 15683970.

25. Breitve MH, Hynninen MJ, Brønnick K, Chwiszczuk LJ, Auestad BH, Aarsland D, et al. A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer's disease. Alzheimers Res Ther. 2016; 8:3. PMID: 26812908.

26. Somme J, Fernández-Martínez M, Molano A, Zarranz JJ. Neuropsychiatric symptoms in amnestic mild cognitive impairment: increased risk and faster progression to dementia. Curr Alzheimer Res. 2013; 10:86–94. PMID: 23016837.

27. Palmer K, Berger AK, Monastero R, Winblad B, Bäckman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology. 2007; 68:1596–1602. PMID: 17485646.

28. Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry. 2013; 21:685–695. PMID: 23567400.

29. Liu HC, Wang PN, Wang HC, Lin KN, Hong CJ, Liu CY, et al. Conversion to dementia from questionable dementia in an ethnic Chinese population. J Geriatr Psychiatry Neurol. 2007; 20:76–83. PMID: 17548776.

30. Brodaty H, Heffernan M, Draper B, Reppermund S, Kochan NA, Slavin MJ, et al. Neuropsychiatric symptoms in older people with and without cognitive impairment. J Alzheimers Dis. 2012; 31:411–420. PMID: 22571979.

31. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the national comorbidity survey follow-up. Psychol Med. 2008; 38:365–374. PMID: 18047766.

32. Reisberg B, Auer SR, Monteiro IM. Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int Psychogeriatr. 1996; 8(Suppl 3):301–308. discussion 351-354. PMID: 9154579.

33. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997; 48(5 Suppl 6):S10–S16.

34. Shankar KK, Walker M, Frost D, Orrell MW. The development of a valid and reliable scale for rating anxiety in dementia (RAID). Aging Ment Health. 1999; 3:39–49.

35. LaBarge E. A preliminary scale to measure the degree of worry among mildly demented Alzheimer disease patients. Phys Occup Ther Geriatr. 1993; 11:43–57.

36. James I. Using a cognitive rationale to conceptualize anxiety in people with dementia. Behav Cogn Psychother. 1999; 27:345–351.

37. Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, et al. Risk factors for dementia with Lewy bodies: a case-control study. Neurology. 2013; 81:833–840. PMID: 23892702.

38. Mah L, Binns MA, Steffens DC. Alzheimer's Disease Neuroimaging Initiative. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Am J Geriatr Psychiatry. 2015; 23:466–476. PMID: 25500120.

39. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci. 2006; 26:9047–9056. PMID: 16943563.

40. Erickson K, Drevets W, Schulkin J. Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neurosci Biobehav Rev. 2003; 27:233–246. PMID: 12788335.

41. Ramakers IH, Verhey FR, Scheltens P, Hampel H, Soininen H, Aalten P, et al. Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychol Med. 2013; 43:911–920. PMID: 22954311.

42. Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry. 2003; 183:248–254. PMID: 12948999.

43. Nordhus IH, Pallesen S. Psychological treatment of late-life anxiety: an empirical review. J Consult Clin Psychol. 2003; 71:643–651. PMID: 12924668.

44. Spector A, Charlesworth G, King M, Lattimer M, Sadek S, Marston L, et al. Cognitive-behavioural therapy for anxiety in dementia: pilot randomised controlled trial. Br J Psychiatry. 2015; 206:509–516. PMID: 25698766.

45. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005; 19:567–596. PMID: 16272179.

46. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996; 25:273–278. PMID: 8831871.

47. Foy A, O'Connell D, Henry D, Kelly J, Cocking S, Halliday J. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol A Biol Sci Med Sci. 1995; 50:M99–M106. PMID: 7874596.

48. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005; 293:596–608. PMID: 15687315.

49. Katz IR, Reynolds CF 3rd, Alexopoulos GS, Hackett D. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc. 2002; 50:18–25. PMID: 12028242.

50. Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, et al. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr. 2002; 14:389–404. PMID: 12670060.

51. National Collaborating Centre for Mental Health, National Collaborating Centre for Primary Care. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care (NICE clinical guideline 113). London: National Institute for Health and Clinical Excellence;2011.

52. Clerici F, Vanacore N, Elia A, Spila-Alegiani S, Pomati S, Da Cas R, et al. Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study. Neurol Sci. 2012; 33:23–31. PMID: 21584738.

53. Moríñigo A, Blanco M, Labrador J, Martín J, Noval D. Risperidone for resistant anxiety in elderly persons. Am J Geriatr Psychiatry. 2005; 13:81–82.

54. McIntyre A, Gendron A, McIntyre A. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. Depress Anxiety. 2007; 24:487–494. PMID: 17177199.

55. Kwak YT, Yang YS, Jang HR. Understanding of antipsychotics in elderly patients with dementia. Dement Neurocogn Disord. 2015; 14:53–69.